These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 22020326)

  • 21. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A biphasic endothelial stress-survival mechanism regulates the cellular response to vascular endothelial growth factor A.
    Latham AM; Odell AF; Mughal NA; Issitt T; Ulyatt C; Walker JH; Homer-Vanniasinkam S; Ponnambalam S
    Exp Cell Res; 2012 Nov; 318(18):2297-311. PubMed ID: 22796052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer.
    Rydén L; Linderholm B; Nielsen NH; Emdin S; Jönsson PE; Landberg G
    Breast Cancer Res Treat; 2003 Dec; 82(3):147-54. PubMed ID: 14703061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth.
    Wicki A; Rochlitz C; Orleth A; Ritschard R; Albrecht I; Herrmann R; Christofori G; Mamot C
    Clin Cancer Res; 2012 Jan; 18(2):454-64. PubMed ID: 22065082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression.
    Mannell HK; Pircher J; Chaudhry DI; Alig SK; Koch EG; Mettler R; Pohl U; Krötz F
    Cardiovasc Res; 2012 Jan; 93(1):111-9. PubMed ID: 22002459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway.
    Kumar B; Chile SA; Ray KB; Reddy GE; Addepalli MK; Kumar AS; Ramana V; Rajagopal V
    Angiogenesis; 2011 Sep; 14(3):371-80. PubMed ID: 21698469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
    Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimerin-2 maintains vascular stability and permeability.
    Pellicani R; Poletto E; Andreuzzi E; Paulitti A; Doliana R; Bizzotto D; Braghetta P; Colladel R; Tarticchio G; Sabatelli P; Bucciotti F; Bressan G; Iozzo RV; Colombatti A; Bonaldo P; Mongiat M
    Matrix Biol; 2020 May; 87():11-25. PubMed ID: 31422156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
    Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
    Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
    Ngan BY; Forte V; Campisi P
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.
    Tang N; Wang L; Esko J; Giordano FJ; Huang Y; Gerber HP; Ferrara N; Johnson RS
    Cancer Cell; 2004 Nov; 6(5):485-95. PubMed ID: 15542432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
    Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP
    FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
    Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
    Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
    Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
    Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
    Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
    Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.